Seacross Pharma (Europe) Limited
SpainAll drugs from this manufacturer
-
It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Dosage form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg -
It is used to treat various types of cancer, such as leukemias, lymphomas, ovarian cancer, breast cancer, lung cancer, bone cancer (Ewing sarcoma), and tumors of the central nervous system. It is also used to prepare for bone marrow transplants and, occasionally, to treat certain serious autoimmune diseases.
Dosage form: powder for injectable solution and for perfusion
Active substance Dosage cyclophosphamide monohydrate 1.069 mg -
It is used to treat various types of cancer, such as leukemia, lymphomas, ovarian cancer, breast cancer, lung cancer, Ewing sarcoma, and neuroblastoma. It is also used in preparation for bone marrow transplants and, occasionally, to treat serious autoimmune diseases such as lupus nephritis or Wegener's granulomatosis.
Dosage form: powder for injectable solution and for perfusion
Active substance Dosage cyclophosphamide monohydrate 534,5 mg -
It is used for the treatment of advanced or early breast cancer, certain types of lung cancer, prostate cancer, gastric cancer, and head and neck cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage docetaxel 20 mg -
It is used to help release stem cells from the bone marrow into the bloodstream so they can be collected, stored, and used later in a transplant. It is prescribed in adults with lymphoma or multiple myeloma, and in children aged 1 to less than 18 years with lymphoma or solid tumors.
Dosage form: solution for injection
Active substance Dosage plerixafor 20 mg/ml -
It is used to prepare the patient before a bone marrow transplant, acting to destroy bone marrow cells to allow for the reception of new stem cells that produce healthy blood cells.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage tiotepa 100 mg -
It is used to prepare patients (adults, children, and adolescents) for a bone marrow transplant, acting by destroying bone marrow cells to allow for the reception of new stem cells.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage tiotepa 15 mg -
It is used to treat seizures that affect the whole body (generalized seizures, such as absence seizures or tonic-clonic seizures) and seizures that affect a part of the body (focal seizures).
Dosage form: solution for injection and for infusion
Active substance Dosage sodium valproate 100 mg/ml -
It is used to treat serious, life-threatening fungal infections, such as invasive aspergillosis, candidemia, infections caused by Scedosporium sp. or Fusarium sp., and to prevent fungal infections in patients who have undergone a bone marrow transplant.
Dosage form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg -
It is used to treat osteoporosis in postmenopausal women and adult men, osteoporosis caused by corticosteroid use, and Paget's disease in adults. It is also used in patients who have suffered a recent hip fracture due to low-impact trauma.
Dosage form: solution for infusion
Active substance Dosage zoledronic acid monohydrate 0,0533 mg/ml